Avirmax Biopharma Inc. Will Present at the 26th ASGCT 2023 Annual Conference in Los Angeles

HAYWARD, Calif., May 17, 2023 /PRNewswire/ — Avirmax Biopharma Inc. (ABI), Chief Executive and Scientific Officer, Shengjiang Shawn Liu will present results of a three-year study that systematically compared the recombinant adeno-associated virus (rAAV) vector products manufactured using insect Sf9 and human HEK293 cell culture systems at the 26th ASGCT annual conference in Los Angeles, … Read more

Grand Opening of Avirmax CMC Inc’s Gene Therapy CDMO Facility

Avirmax CMC Inc., an invaluable resource for accelerating AAV gene therapy research and development Tweet this Avirmax CMC Inc. has exemplary expertise in AAV vector design, engineering, process development, GMP manufacturing, analytical testing and characterization that enable clients to obtain full services in AAV product supply from transgene DNA sequences into final AAV final products. … Read more